StephenSFlitmanMD

Neurology • Phoenix, AZ

Headache

Medical Director at 21st Century Neurology

Join to view full profile

Dr. Flitman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Flitman's full profile

Already have an account?

Office
2601 N 3rd St
Ste 125
Phoenix, AZ 85004
Phone+1 602-265-6500

Fax+1 602-265-6586

Education & Training

Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 1991 - 1994
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1990 - 1991
Albany Medical CollegeClass of 1990

Certifications & Licensure

AZ State Medical License 1992 - 2026
MD State Medical License 1994 - 1998
National Board of Physicians and Surgeons Neurology

Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes Start of enrollment: 2017 Apr 01
Withdrawn
Phase 3
18F-AV-1451 Autopsy Study Start of enrollment: 2015 Sep 01
Completed
Phase 3
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
COMPLETED
PHASE3
Roles: Contact
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2020 Oct 27
COMPLETED
PHASE3
Roles: Contact
Simufilam 100 Mg for Mild-to-Moderate Alzheimer's Disease Start of enrollment: 2021 Nov 03
COMPLETED
PHASE3
Roles: Contact, Principal Investigator
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. Start of enrollment: 2018 Oct 10
COMPLETED
PHASE2
Roles: Contact, Principal Investigator
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects Start of enrollment: 2024 Apr 02
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

11 citations
Treatment of migraine with occipital nerve blocks using only corticosteroids.
Joshua Tobin, Stephen Flitman
Headache. 2011-01-01
63 citations
Occipital Nerve Blocks: When and What to Inject?
Joshua Tobin, Stephen Flitman
Headache. 2009-11-01
36 citations
Occipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate.
Joshua Tobin, Stephen Flitman
Headache. 2009-11-01

Press Mentions

Chief Branding Strategist of Impact Branding Speaks at the Annual AANLCP ConferenceFebruary 28th, 2017